pediatric vogt-koyanagi-harada (vkh)-associated panuveitis: clinical course and management

نویسندگان

مریم آل طه

m aletaha تهران- پاسداران- بوستان نهم- بیمارستان لبافی نژاد- مرکز تحقیقات چشم مسعود سهیلیان

m soheilian تهران- پاسداران- بوستان نهم- بیمارستان لبافی نژاد- مرکز تحقیقات چشم

چکیده

purpose: to assess the clinical course, determine the efficacy and safety of oral methotrexate in the control of intraocular inflammation and evaluate the outcomes of lensectomy-vitrectomy and goniosynechiolysis in pediatric vkh-associated panuveitis. methods: in this retrospective non-comparative interventional case series, 10 patients (20 eyes) with pediatric vkh-associated panuveitis (onset of disease at age 14 years or younger) were studied. all patients underwent stepwise medical treatment consisting of oral prednisolone (0.5-1 mg/kg), supplemented by oral methotrexate (5-7.5 mg/wk) in refractory cases. surgical intervention was performed for complications such as visually significant cataracts and secondary glaucoma and included pars plana lensectomy-vitrectomy and peripheral anterior synechiolysis in a one-stage procedure. control of inflammation, corticosteroid requirement, visual acuity, and intraocular pressure (iop) were the main outcome measures. results: ten consecutive patients with minimum follow up of six months were analyzed. all patients were initially treated with oral corticosteroids; methotrexate was additionally required in six subjects. in all eyes, inflammation decreased and vision was preserved or improved. side effects of methotrexate were mild and transient. nine eyes of five patients underwent combined lensectomy and vitrectomy. the procedure was successful in all eyes without any exacerbation of inflammation. eight eyes had elevated iop, six of which underwent peripheral anterior synechiolysis at the time of lensectomy-vitrectomy. iop was controlled after the procedure in all eyes with timolol only. overall, final visual acuity was ³20/40 in 30% of the eyes and <20/200 in only 20%. conclusion: pediatric vkh-associated panuveitis seems to follow an aggressive course; the rate of cataracts and secondary glaucoma seems to be high. oral methotrexate is a safe and effective adjunct and displays steroid-sparing properties in the control of inflammation. surgical interventions including peripheral anterior synechiolysis in addition to pars plana lensectomy and vitrectomy may be effective in controlling iop in eyes with cataract and glaucoma. key words: vogt-koyanagi-harada (vkh) syndrome, children, panuveitis

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Vogt-koyanagi-harada Syndrome

CASE PRESENTATION A 20 year old Asian male was referred with the complaint of decreased vision in both eyes for a year. His past medical and surgical histories were unremarkable. His family history revealed thyroid disease in his mother. Review of systems were remarkable for alopecia and headache at the time when his eye problems began. The first eye exam from his referring ophthalmologist reve...

متن کامل

Vogt Koyanagi Harada syndrome.

An 11-year-old female girl presented to us with fever of 3 months duration. Additionally she had vitiligo for two years and deafness and alopecia for the last 3 months. Two years ago, the patient had an episode of pain, watering and congestion of both eyes (suggestive of nontraumatic uveitis) for 2 weeks. She responded to therapy in the form of eye drops and oral medication (Ayurvedic medicine)...

متن کامل

Vogt-Koyanagi-Harada disease.

Vogt-Koyanagi-Harada disease is a chronic, granulomatous systemic autoimmune disease with manifestations in the ocular, central nervous, auditory, and integumentary systems. The target of attack seems to be antigens associated with melanocytes. Patients are usually of Asian, Middle Eastern, Asian Indian, Native American, or Hispanic ethnicity, and complain of neurologic symptoms quickly followe...

متن کامل

Vogt-Koyanagi-Harada disease.

Vogt-Koyanagi-Harada (VKH) disease, also known as uveomeningitic syndrome, is an idiopathic multisystem inflammatory disease with bilateral uveitis. Patients with bilateral anterior uveitis with vitiligo, poliosis, alopecia, and dysacousia were first described by Vogt in 1906 and then Koyanagi in 1929. Harada described a case of posterior uveitis with exudative retinal detachment and pleocytosi...

متن کامل

Clinical spectrum and management options in Vogt–Koyanagi–Harada disease

PURPOSE The aim of this study was to describe the clinical features, treatment options, and visual outcome of Vogt-Koyanagi-Harada (VKH) disease patients over a 9-year period. METHOD A retrospective chart analysis of 32 patients with VKH, from January 2007 to December 2015, at a tertiary care government medical college eye hospital in South India. RESULTS A total of 32 patients were diagnos...

متن کامل

Vogt-Koyanagi-Harada Syndrome

97 Vogt-Koyanagi-Harada syndrome is generally a rare multisystemic autoimmune disorder involving with pigmented structures, such as the eye, meninges, inner ear and skin. The syndrome typically presents as an episode of bilateral panuveitis after prodromal symptoms similar to aseptic meningitis. Auditory disturbances include tinnitus, hearing loss and vertigo. We report the case of a 74-year-ol...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
بینا

جلد ۱۱، شماره ۴، صفحات ۵۰۵-۵۱۳

کلمات کلیدی

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023